S&P 500 7,637.76 +1.14%
Nasdaq 26,418.30 +1.69%
S&P/TSX 35,874.26 +1.08%
Apple 337.00 +1.38%
Nvidia 219.34 +2.54%
Microsoft 497.75 +1.52%
Shopify 180.01 −0.97%
Royal Bank 284.93 +0.66%
CAD/USD 0.7147 −0.03%
CLOSED · 02:10 ET
Market ClerkRecap
Fri Sep 18 · markets closed3 signals on Sep 17300 insider buys this week · $205.1MCIRO short report next: Sep 29The week ahead

INVA

Innoviva, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
21.05
−0.15 −0.71%
USD · close Sep 17

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.5BP/E 5.1DIV YIELD FCF YIELD 12.46%REV TTM $440M +18.8%NET INCOME $357.2M +824.3%NET DEBT $168.7M52W 16.67 – 24.24SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$119.6M+19.3%75.8%$50.9M−$83.4M−231.0%-1.14$52M$429K$51.5MAug 5
Q1 2026 · Mar 31$98M+10.6%77.4%$38.2M$186.6M2.22$35.3M$492K$34.8MAug 5
Q4 2025 · Dec 31derived$114.6M+24.8%66.0%$39M$164.2M+707.4%1.95$54.5M$10K$54.5MFeb 25
Q3 2025 · Sep 30$107.8M+20.4%70.1%$34.6M$89.9M+7312.0%1.08$49.7M$1.1M$48.6MNov 5
Q2 2025 · Jun 30$100.3M+0.4%82.9%$48.8M$63.7M0.77$44.1M$0$44.1MAug 5
Q1 2025 · Mar 31$88.6M+14.4%82.7%$41.4M−$46.6M−227.5%-0.74$48.6M$0$48.6MAug 5
Q4 2024 · Dec 31derived$91.8M+7.0%85.1%$43.1M$20.3M−67.0%0.31$59.2M$0$59.2MFeb 25
Q3 2024 · Sep 30$89.5M+33.1%81.6%$43.2M$1.2M−98.5%0.02$48.7M$270K$48.4MNov 5
Q2 2024 · Jun 30$99.9M85.1%$54.7M−$34.7M-0.55$43.7M$0$43.7MNov 5
Q1 2024 · Mar 31$77.5M77.5%$25.8M$36.5M0.46$37M$0$37MNov 5
Q4 2023 · Dec 31derived$85.8M$61.5M0.75$33.3M$151K$33.1MFeb 25
Q3 2023 · Sep 30$67.3M$82M0.98$43.9M$227K$43.7MNov 6

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$411.3M74.8%$163.7M$271.2M65.9%3.30$196.9M$1.1M$195.8M$4.5M
FY2024 · to Dec 31$358.7M82.6%$166.9M$23.4M6.5%0.36$188.7M$270K$188.4M$14.8M
FY2023 · to Dec 31$310.5M79.2%$113.9M$179.7M57.9%2.20$141.1M$411K$140.7M$75.7M
FY2022 · to Dec 31$331.3M$220.3M66.5%2.37$201.7M$67K$201.7M$8.5M
FY2021 · to Dec 31$391.9M$375.1M$368.8M94.1%2.87$363.8M$0$363.8M$394.1M$0
FY2020 · to Dec 31$336.8M$321.1M$293.8M87.2%2.02$313.1M$13K$313.1M$0$0

Every number comes from Innoviva, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch INVA. Know when insiders buy.
One email the day a filing lands. Free.